Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Assets Average: 2020-2025

Historic Assets Average for Benitec Biopharma (BNTC) over the last 4 years, with Mar 2025 value amounting to $92.1 million.

  • Benitec Biopharma's Assets Average rose 406.92% to $92.1 million in Q1 2025 from the same period last year, while for Mar 2025 it was $92.1 million, marking a year-over-year increase of 406.92%. This contributed to the annual value of $28.3 million for FY2024, which is 443.01% up from last year.
  • As of Q1 2025, Benitec Biopharma's Assets Average stood at $92.1 million, which was up 24.64% from $73.9 million recorded in Q4 2024.
  • Benitec Biopharma's Assets Average's 5-year high stood at $92.1 million during Q1 2025, with a 5-year trough of $6.3 million in Q2 2023.
  • Moreover, its 3-year median value for Assets Average was $24.2 million (2023), whereas its average is $37.2 million.
  • Per our database at Business Quant, Benitec Biopharma's Assets Average crashed by 53.93% in 2022 and then skyrocketed by 429.87% in 2024.
  • Over the past 5 years, Benitec Biopharma's Assets Average (Quarterly) stood at $15.9 million in 2021, then declined by 5.75% to $15.0 million in 2022, then spiked by 61.25% to $24.2 million in 2023, then spiked by 205.42% to $73.9 million in 2024, then skyrocketed by 406.92% to $92.1 million in 2025.
  • Its last three reported values are $92.1 million in Q1 2025, $73.9 million for Q4 2024, and $60.5 million during Q3 2024.